Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Phase I study to evaluate safety and immunogenicity in healthy adult subjects following a single dose administration of Meningococcal (Group A, C, W-135, X, and Y)-CRM197 Conjugate vaccine
Epistemonikos ID: 3ce2eaaffaa57f064c9673a09fe67a1b21c1a24e
First added on: Feb 19, 2024